{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:45:44Z","timestamp":1790671544973,"version":"4.1.0"},"reference-count":116,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NPF (National Psoriasis Foundation, USA)","award":["2020\u20132023"],"award-info":[{"award-number":["2020\u20132023"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Psoriasis is a chronic inflammatory skin disease, which affects 2\u20134% of the population worldwide. T-cell derived factors such as Th17 and Th1 cytokines or cytokines such as IL-23, which favors Th17-expansion\/differentiation, dominate in the disease. Therapies targeting these factors have been developed over the years. An autoimmune component is present, as autoreactive T-cells specific for keratins, the antimicrobial peptide LL37 and ADAMTSL5 have been described. Both autoreactive CD4 and CD8 T-cells exist, produce pathogenic cytokines, and correlate with disease activity. Along with the assumption that psoriasis is a T-cell-driven disease, Tregs have been studied extensively over the years, both in the skin and in circulation. This narrative review resumes the main findings about Tregs in psoriasis. We discuss how Tregs increase in psoriasis but are impaired in their regulatory\/suppressive function. We debate the possibility that Tregs convert into T-effector cells under inflammatory conditions; for instance, they may turn into Th17-cells. We put particular emphasis on therapies that seem to counteract this conversion. We have enriched this review with an experimental section analyzing T-cells specific for the autoantigen LL37 in a healthy subject, suggesting that a shared specificity may exist between Tregs and autoreactive responder T-cells. This suggests that successful psoriasis treatments may, among other effects, restore Tregs numbers and functions.<\/jats:p>","DOI":"10.3390\/ijms24054348","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T04:33:56Z","timestamp":1677040436000},"page":"4348","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Autoreactive T-Cells in Psoriasis: Are They Spoiled Tregs and Can Therapies Restore Their Functions?"],"prefix":"10.3390","volume":"24","author":[{"given":"Immacolata","family":"Pietraforte","sequence":"first","affiliation":[{"name":"Department of Oncology and Molecular Medicine, Istituto Superiore di Sanit\u00e0, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6924-3826","authenticated-orcid":false,"given":"Loredana","family":"Frasca","sequence":"additional","affiliation":[{"name":"National Center for Drug Research and Evaluation, Istituto Superiore di Sanit\u00e0, Viale Regina Elena, 299, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/1346-8138.13186","article-title":"Psoriasis: Behind the scenes","volume":"43","author":"Furue","year":"2016","journal-title":"J. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/gene.2009.11","article-title":"Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis","volume":"10","author":"Elder","year":"2009","journal-title":"Genes Immun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12016-016-8535-x","article-title":"The Inflammatory Response in Psoriasis: A Comprehensive Review","volume":"50","author":"Deng","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1084\/jem.20172094","article-title":"Foxp3+ T reg cells control psoriasiform inflammation by restraining an IFN-I-driven CD8+ T cell response","volume":"215","author":"Stockenhuber","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: Mechanism underlying unrestrained pathogenic effector T cell proliferation","volume":"174","author":"Sugiyama","year":"2005","journal-title":"J. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.4049\/jimmunol.0803721","article-title":"IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells","volume":"183","author":"Goodman","year":"2009","journal-title":"J. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"715901","DOI":"10.3389\/fcell.2021.715901","article-title":"Phenotypic and Functional Diversity in Regulatory T Cells","volume":"9","author":"Sjaastad","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e1005","DOI":"10.1002\/cti2.1005","article-title":"Human FOXP3(+) T regulatory cell heterogeneity","volume":"7","author":"Mohr","year":"2018","journal-title":"Clin. Transl. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","article-title":"Human FOXP3(+) regulatoryT cell heterogeneity and function in autoimmunity and cancer","volume":"50","author":"Wing","year":"2019","journal-title":"Immunity"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ni.1731","article-title":"The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation","volume":"10","author":"Koch","year":"2009","journal-title":"Nat. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature22360","article-title":"Stability and function of regulatory T cells expressing the transcription factor T-bet","volume":"546","author":"Levine","year":"2017","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1172\/JCI57456","article-title":"GATA3 controls Foxp3? regulatory T cell fate during inflammation in mice","volume":"121","author":"Wohlfert","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"eaat6280","DOI":"10.1126\/science.aat6280","article-title":"Commensal-specific T cell plasticity promotes rapid tissue adaptation to injury","volume":"363","author":"Harrison","year":"2019","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.immuni.2011.08.012","article-title":"An essential role of the transcriptionfactor GATA-3 for the function of regulatory T cells","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.immuni.2015.02.004","article-title":"Regulatory T cell reprogramming toward a Th2-cell like lineage impairs oral tolerance and promotes food allergy","volume":"42","author":"Burton","year":"2015","journal-title":"Immunity"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.aaa9420","article-title":"Individual intestinal symbionts induce a distinct population of RORgamma(+) regulatory T cells","volume":"349","author":"Sefik","year":"2015","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.aac5560","article-title":"Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine","volume":"351","author":"Kim","year":"2016","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/jid.2011.139","article-title":"Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin","volume":"131","author":"Bovenschen","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1053\/j.gastro.2010.12.002","article-title":"Characterization of interleukin-17-producing regulatory T cells in infame intestinal mucosa from patients with inflammatory bowel diseases","volume":"140","author":"Hovhannisyan","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1172\/JCI72932","article-title":"Memory regulatory T cells reside in human skin","volume":"124","author":"Pauli","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/nm.4147","article-title":"An asthma-associated IL4R variant exacerbates airway inflammation by promoting conversion of regulatory T cells to TH17- like cells","volume":"22","author":"Massoud","year":"2016","journal-title":"Nat. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Kim, S.H., Oh, J., Roh, W.S., Park, J., Chung, K.B., Lee, G.H., Lee, Y.S., Kim, J.H., Lee, H.K., and Lee, H. (2023). Pellino-1 promotes intrinsic activation of skin-resident IL-17A-producing T cells in psoriasis. J. Allergy Clin. Immunol., in press.","DOI":"10.1016\/j.jaci.2022.12.823"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Samat, A.A.K., van der Geest, J., Vastert, S.J., van Loosdregt, J., and van Wijk, F. (2021). Tissue\u2013Resident Memory T Cells in Chronic Inflammation\u2014Local Cells with Systemic Effects?. Cells, 10.","DOI":"10.3390\/cells10020409"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.chom.2017.03.001","article-title":"Commensal microbes and hair follicle morphogenesis coordinately drive Treg migration into neonatal skin","volume":"21","author":"Scharschmidt","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e12846","DOI":"10.1111\/sji.12846","article-title":"The CCL20 and CCR6 axis in psoriasis","volume":"91","author":"Furue","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e20201234","DOI":"10.1084\/jem.20201234","article-title":"T reg cell-intrinsic requirements for ST2 signaling in health and neuroinflammation","volume":"218","author":"Hemmers","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coi.2014.09.004","article-title":"IL-33: An alarmin cytokine with crucial roles in innate immunity, inflammation and allergy","volume":"31","author":"Cayrol","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41385-019-0153-5","article-title":"The alarmins IL-1 and IL-33 differentially regulate the functional specialisation of Foxp3(+) regulatory T cells during mucosal inflammation","volume":"12","author":"Alvarez","year":"2019","journal-title":"Mucosal. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"20696","DOI":"10.1073\/pnas.2000372117","article-title":"Proenkephalin(+) regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function","volume":"117","author":"Shime","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.1502139","article-title":"Cutting edge: Regulatory T cells facilitate cutaneous wound healing","volume":"196","author":"Nosbaum","year":"2016","journal-title":"J. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.4049\/jimmunol.177.7.4488","article-title":"The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin homing receptors","volume":"177","author":"Hirahara","year":"2006","journal-title":"J. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4049\/jimmunol.161.2.963","article-title":"CD4+ T cells migrate into inflamed skin only if they express ligands for E- and P-selectin","volume":"161","author":"Tietz","year":"1998","journal-title":"J. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"Mourits","year":"2009","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/sji.12404","article-title":"Characterization of Th17 and FoxP3 (+) Treg cells in pediatric psoriasis patients","volume":"83","author":"Zhang","year":"2016","journal-title":"Scand. J. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bjd.19380","article-title":"Role of regulatory T cells in psoriasis pathogenesis and treatment","volume":"184","author":"Nussbaum","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jdermsci.2015.11.007","article-title":"Impaired function of regulatory T cells in patients with psoriasis is mediated by phosphorylation of STAT3","volume":"81","author":"Yang","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2013.10.009","article-title":"Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4(+) T cells of psoriasis vulgaris","volume":"150","author":"Zhao","year":"2014","journal-title":"Clin. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/bjd.16560","article-title":"Methotrexate restores the function of peripheral blood regulatory T cells in psoriasis vulgaris via the CD73\/AMPK\/ mTOR pathway","volume":"179","author":"Yan","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.clim.2013.06.007","article-title":"Psoriasis patients exhibit impairment of the high potency CCR5(+) T regulatory cell subset","volume":"149","author":"Soler","year":"2013","journal-title":"Clin. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.clindermatol.2007.08.015","article-title":"Triggering psoriasis: The role of infections and medications","volume":"25","author":"Fry","year":"2007","journal-title":"Clin. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/bs.pmbts.2015.07.013","article-title":"The special relationship in the development and function of T helper 17 and regulatory Tt cells","volume":"136","author":"Lochner","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"eaau2042","DOI":"10.1126\/sciimmunol.aau2042","article-title":"The TNFRSF members CD27 and OX40 coordinately limit TH17 differentiation in regulatory T cells","volume":"3","author":"Remedios","year":"2018","journal-title":"Sci. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1684\/ejd.2011.1362","article-title":"CD4+ CD25+ T-regulatory cells in psoriasis. Correlation between their numbers and biologics-induced clinical improvement","volume":"21","author":"Richetta","year":"2011","journal-title":"Eur. J. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clim.2009.11.008","article-title":"Increased T17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity","volume":"135","author":"Zhang","year":"2010","journal-title":"Clin. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/ncomms6621","article-title":"The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis","volume":"5","author":"Lande","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Quaglino, P., Ortoncelli, M., Comessatti, A., Ponti, R., Novelli, M., Bergallo, M., Costa, C., Cicchelli, S., Savoia, P., and Bernengo, M.G. (2009). Circulating CD4+CD25 bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients. Dermatology, 250\u2013258.","DOI":"10.1159\/000238305"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000330330","article-title":"Th1,Th2, Th17 and Regulatory T Cell Pattern in Psoriatic Patients: Modulation of Cytokines and Gene Targets Induced by Etanercept Treatment and Correlation with Clinical Response","volume":"223","author":"Quaglino","year":"2011","journal-title":"Dermatology"},{"key":"ref_53","first-page":"236060","article-title":"Immunologic biomarkers for clinical and therapeutic management of psoriasis","volume":"2014","author":"Bianchi","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2133.2010.09650.x","article-title":"Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis","volume":"162","author":"Diluvio","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jdermsci.2019.07.006","article-title":"Anti-IL-17A and IL-23p19 antibodies but not anti-TNF\u03b1 antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis","volume":"95","author":"Shimizu","year":"2019","journal-title":"J. Dermatol. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"17675","DOI":"10.1038\/s41598-019-53240-z","article-title":"IL-23 induces regulatory T cell plasticity with implications for inflammatory skin diseases","volume":"9","author":"Kannan","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jid.2021.01.005","article-title":"Differential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. Secukinumab","volume":"141","author":"Mehta","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/bjd.20963","article-title":"The biological basis of disease recurrence in psoriasis: A historical perspective and current models","volume":"186","author":"Puig","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2217\/imt-2020-0040","article-title":"Guselkumab in the treatment of moderate-to-severe plaque psoriasis","volume":"12","author":"Puig","year":"2020","journal-title":"Immunotherapy"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jamadermatol.2020.0723","article-title":"Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients with Moderate to Severe Plaque Psoriasis","volume":"156","author":"Blauvelt","year":"2021","journal-title":"JAMA Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/jdv.16964","article-title":"Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: Post hoc analysis through 64 weeks from reSURFACE 1 trial","volume":"35","author":"Warren","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1759720X17735756","article-title":"Anti-interleukin and interleukin therapies for psoriasis: Current evidence and clinical usefulness","volume":"9","author":"Tsai","year":"2017","journal-title":"Ther. Adv. Musculoskel. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jbspin.2011.06.011","article-title":"Psoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab","volume":"79","author":"Ogata","year":"2012","journal-title":"Jt. Bone Spine"},{"key":"ref_64","first-page":"563571","article-title":"Efficacy and safety of biologics targeting interleukin 6, -12\/23 and -17 pathways for peripheral psoriatic arthritis: A network meta-analysis","volume":"57","author":"Wu","year":"2018","journal-title":"Rheumatology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/art.39700","article-title":"The Efficacy and Safety of Clazakizumab, an Anti-Interleukin-6 Monoclonal Antibody, in a Phase IIb Study of Adults with Active Psoriatic Arthritis","volume":"68","author":"Mease","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/RHU.0000000000000583","article-title":"A Systematic Review and Meta-analysis of Novel Interleukin Inhibitors\u2019 Efficacy and Safety in the Treatment of Psoriatic Arthritis","volume":"1","author":"Bilal","year":"2018","journal-title":"J. Clin. Rheumatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/1744666X.2020.1672537","article-title":"Advances in phototherapy for psoriasis and atopic dermatitis","volume":"15","author":"Varga","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jdermsci.2017.01.001","article-title":"Bath\u2013PUVA therapy improves impaired resting regulatory T cells and increases activated regulatory T cells in psoriasis","volume":"86","author":"Kubo","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Furuhashi, T., Saito, C., Torii, K., Nishida, E., Yamazaki, S., and Morita, A. (2013). Photo (chemo)therapy Reduces Circulating Th17 Cells and Restores Circulating Regulatory T Cells in Psoriasis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0054895"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/bjd.13930","article-title":"Levels and function of regulatory T cells in patients with polymorphic light eruption: Relation to photohardening","volume":"173","author":"Schweintzger","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/nm1518","article-title":"Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells","volume":"12","author":"Loser","year":"2006","journal-title":"Nat. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5312\/wjo.v3.i9.142","article-title":"RANKL-RANK interaction in immune regulatory systems","volume":"3","author":"Akiyama","year":"2012","journal-title":"World J. Orthop."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/1523-1747.ep12542071","article-title":"Systemic Suppression of Contact Hypersensitivity in Mice by Psoralen Plus UV A Radiation (PUV A)","volume":"81","author":"Kripke","year":"1983","journal-title":"J. Investig. Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/09546634.2017.1309349","article-title":"Retinoids: A journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects","volume":"28","author":"Khalil","year":"2017","journal-title":"J. Dermatol. Treat."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1145697","article-title":"Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid","volume":"317","author":"Mucida","year":"2007","journal-title":"Science"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood-2007-06-096438","article-title":"Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3\/Stat5 independent signaling pathway","volume":"111","author":"Elias","year":"2008","journal-title":"Blood"},{"key":"ref_77","first-page":"1675","article-title":"Peripheral blood regulatory T cell measurements correlate with serum vitamin D level in patients with psoriasis","volume":"9","author":"Mattozzi","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jdermsci.2018.08.007","article-title":"The vitamin D3 analog, maxacalcitol, reduces psoriasiform skin inflammation by inducing regulatory T cells and downregulating IL-23 and IL-17 production","volume":"92","author":"Hau","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4049\/jimmunol.178.1.145","article-title":"1,25-dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells","volume":"178","author":"Penna","year":"2007","journal-title":"J. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.4049\/jimmunol.164.9.4443","article-title":"Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells","volume":"164","author":"Piemonti","year":"2000","journal-title":"J. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.4049\/jimmunol.167.4.1945","article-title":"Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance","volume":"167","author":"Gregori","year":"2001","journal-title":"J. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.det.2014.09.006","article-title":"An update on topical therapies for mild\/moderate psoriasis","volume":"33","year":"2015","journal-title":"Dermatol. Clin."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1067\/mai.2003.97","article-title":"Update on glucocorticoid action and resistance","volume":"111","author":"Leung","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1358\/dot.2010.46.5.1473264","article-title":"Vitamine D analogue-based therapies for psoriasis","volume":"46","author":"Feldman","year":"2010","journal-title":"Drugs Today"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/09546630903214175","article-title":"Treatment of plaque psoriasis with the two-compound product calcipotriol\/betamethasone dipropionate versus both monotherapies: An immunohistochemical study","volume":"21","author":"Pasch","year":"2010","journal-title":"J. Dermatolog. Treat."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/exd.12575","article-title":"Balance of Treg versus T-effector cells during systemic treatment with adalimumab and topical treatment with calcipotriol-betamethasone dipropionate ointment","volume":"24","author":"Keijsers","year":"2015","journal-title":"Exp. Dermatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2340\/00015555-2579","article-title":"Clinical Efficiency of Topical Calcipotriol\/Betamethasone Treatment in Psoriasis Relies on Suppression of the Inflammatory TNF\u03b1\u2014IL-23\u2014IL-17 Axis","volume":"97","author":"Kubin","year":"2017","journal-title":"Acta Derm. Venereol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1744666X.2021.1919510","article-title":"Efficacy of dimethyl fumarate treatment for moderate-to-severe plaque psoriasis: Presentation extracts from the 29th EADV virtual congress, 29\u201331 October 2020","volume":"17","author":"Mrowietz","year":"2021","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1182\/blood-2010-09-307041","article-title":"Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress","volume":"117","author":"Mougiakakos","year":"2011","journal-title":"Blood"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1182\/blood-2008-09-181040","article-title":"Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress\u2013induced cell death","volume":"113","author":"Mougiakakos","year":"2009","journal-title":"Blood"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/bjd.19229","article-title":"Dimethyl fumarate modulates the Treg\u2013Th17 cell axis in patients with psoriasis","volume":"184","author":"Sulaimani","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1172\/JCI35636","article-title":"The PKC inhibitor AEB071 may be a therapeutic option for psoriasis","volume":"118","author":"Skvara","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1021\/jm200469u","article-title":"Structure-activity relationship and pharmacokinetic studies of sotrastaurin (AEB071), a promising novel medicine for prevention of graft rejection and treatment of psoriasis","volume":"54","author":"Wagner","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1124\/jpet.109.153205","article-title":"The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation","volume":"330","author":"Evenou","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1126\/science.1186068","article-title":"Protein kinase C-theta mediates negative feedback on regulatory T cell function","volume":"328","author":"Ding","year":"2010","journal-title":"Science"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.it.2008.01.005","article-title":"T-cell fate and function: PKC and beyond","volume":"29","author":"Marsland","year":"2008","journal-title":"Trends Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.4049\/jimmunol.176.5.2872","article-title":"Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice","volume":"176","author":"Tan","year":"2006","journal-title":"J. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/jid.2013.459","article-title":"Targeting PKC in human T cells using sotrastaurin (AEB071) preserves regulatory T cells and prevents IL-17 production","volume":"134","author":"He","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40259-019-00333-w","article-title":"Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases","volume":"33","author":"Virtanen","year":"2019","journal-title":"BioDrugs"},{"key":"ref_100","first-page":"4883","article-title":"The JAK inhibitor tofacitinib ameliorates immune-mediated liver injury in mice","volume":"20","author":"Wang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_101","first-page":"1785","article-title":"The Jak Inhibitor CP-690,550 Preserves the Function of CD4+CD25brightFoxP3+ Regulatory T Cells and Inhibits Effector T Cells","volume":"10","author":"Sewgobind","year":"2010","journal-title":"Arab. Archaeol. Epigr."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/rheumatology\/34.7.602","article-title":"Methotrexate action in rheumatoid arthritis: Stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells","volume":"34","author":"Seitz","year":"1995","journal-title":"Br. J. Rheumatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/ced.13795","article-title":"Effect of methotrexate monotherapy on T-cell subsets in the peripheral circulation in psoriasis","volume":"44","author":"Priyadarssini","year":"2019","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fimmu.2012.00190","article-title":"The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway","volume":"3","author":"Ohta","year":"2012","journal-title":"Front. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","article-title":"Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial","volume":"78","author":"Rosenzwajg","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Von Knethen, A., Heinicke, U., Weigert, A., Zacharowski, K., and Br\u00fcne, B. (2020). Histone Deacetylation Inhibitors as Modulators of Regulatory T Cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072356"},{"key":"ref_107","first-page":"95.e2\u2013104.e2","article-title":"Induction of regulatory T cells and correction of cytokine dysbalance by short chain fatty acids\u2014Implications for the therapy of psoriasis","volume":"141","author":"Schwarz","year":"2020","journal-title":"J. Investig. Dermatol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/jid.2010.255","article-title":"Stat3 as a Therapeutic Target for the Treatment of Psoriasis: A Clinical Feasibility Study with STA-21, a Stat3 Inhibitor","volume":"131","author":"Miyoshi","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.4103\/jfmpc.jfmpc_709_19","article-title":"The role of gut microbiome in the pathogenesis of psoriasis and the therapeutic effects of probiotics","volume":"8","author":"Alzahrani","year":"2019","journal-title":"J. Fam. Med. Prim. Care."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1126\/science.aau2688","article-title":"Treg cells\u2014The next frontier of cell therapy","volume":"362","author":"Bluestone","year":"2018","journal-title":"Science"},{"key":"ref_111","first-page":"83","article-title":"Peripheral blood T-cell responses to keratin peptides that share sequences with M proteins are largely restricted to skin-homing CD8+ T cells","volume":"138","author":"Johnston","year":"2008","journal-title":"Scand. J. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1084\/jem.20151093","article-title":"Melanocyte antigen triggers autoimmunity in human psoriasis","volume":"212","author":"Arakawa","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1038\/s41598-020-62480-3","article-title":"Native\/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus","volume":"10","author":"Lande","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"83ra42","DOI":"10.1126\/scitranslmed.3002076","article-title":"Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells","volume":"3","author":"Sagoo","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"9541","DOI":"10.1073\/pnas.95.16.9541","article-title":"The peptide antibiotic LL-37\/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface","volume":"95","author":"Bals","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.it.2017.07.010","article-title":"The Mechanisms of T Cell Selection in the Thymus","volume":"38","author":"Takaba","year":"2017","journal-title":"Trends Immunol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/5\/4348\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:39:05Z","timestamp":1760121545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/5\/4348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":116,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["ijms24054348"],"URL":"https:\/\/doi.org\/10.3390\/ijms24054348","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,22]]}}}